ROBERT RUSSELL: Open Payments
NPI 1801286059 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 26 payments from 11 companies in 2025. Trend: 2023 $478 · 2024 $580 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $107 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Medtronic, Inc. | 2 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Corcept Therapeutics | 2 | $31 |
| Smith+Nephew, Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
Products named: JARDIANCE, Kerendia, SYMPLICITY G3, MOUNJARO, BREZTRI, Korlym, COLLAGENASE SANTYL, Tymlos.
Industry payments across AL — which companies pay providers there.
